BEUDAMED
    15 results · 29ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    Galapogos

    FDA 510(k)
    FDA Class 2 ·Anesthesiology

    OsteoMed

    FDA UDI
    OSTEOMED LLC·00845694007122·1.6mm Pilot Drill, Mandible, Osteopower

    ELMED

    FDA UDI
    ELMED INCORPORATED·00842180102880·DIATHERMY CABLE W/ TRIAX METAL CONNECTOR AND 2-...

    ACUMED

    FDA UDI
    Acumed LLC·10806378014642·2.7mm x 30.0mm Locking Cortical Screw

    Hayden Medical

    FDA UDI
    Hayden Medical, Inc.·00840319706060·Takahashi Ethmoid Forceps 4-1/2" (11.4cm) shaft...

    ACUMED

    FDA UDI
    Acumed LLC·10806378014659·2.7mm x 30.0mm Locking Cortical Screw

    EAV COMBI-2

    FDA 510(k)
    FDA Class 2 ·Neurology

    MODIFICATION TO NC-STAT

    FDA 510(k)
    FDA Class 2 ·Neurology

    DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

    FDA Adverse Event
    Malfunction ·DEXCOM, INC.·Product code QBJ·July 29, 2025

    PARADIGM REAL-TIME INSULIN INFUSION PUMP

    FDA Adverse Event
    Malfunction ·MEDTRONIC MINIMED·Product code OYC·October 24, 2014

    CAPSUREFIX NOVUS

    FDA Adverse Event
    Injury ·MEDTRONIC PUERTO RICO, INC.·Product code DTB·August 11, 2011

    RESERVOIR 1.8ML

    FDA Adverse Event
    Malfunction ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code FRN·July 1, 2013

    SYNVISC (HYLAN G-F 20) INJECTION

    FDA Adverse Event
    Other ·GENZYME BIOSURGERY (RIDGEFIELD)·Product code MOZ·April 25, 2013

    BioGX SARS-CoV-2 Reagents for BD MAX System-IVD PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal specimens Catalog Number: 444213

    FDA Enforcement
    Class II ·Terminated·Becton Dickinson & Co.·April 21, 2021

    Medrad Continuum MR Infusion system- non-wireless system The MEDRAD Continuum MR Infusion System is designed for patients who require medications and other fluids during an MR procedure. It is intended to provide infusion therapy directly prior to, during and immediately after the MR procedure functioning while either stationary or mobile. It is not intended to provide long-term patient care outside the MR environment. The system is to be used by trained medical staff, primarily critical care, emergency room and radiology nursing staff.

    FDA Enforcement
    Class II ·Terminated·Bayer Corp·June 11, 2014